Temasek Holdings, a Singapore based investment company is now a shareholder in HCG Enterprises Limited. Evolvence India Life Sciences Fund, which has been an investor in HCG since 2007, will be exiting their investment to Temasek in the Company. HCG the Bangalore headquartered company runs a network of over 26 cancer care centers. HCG happens to be running Asia’s largest cancer care network. HCG focuses on cancer care treatment, imaging and laboratory services, clinical trials and research services.
Other investors in the company are – Premji Invest, an investment entity owned by Mr. Azim Premji, and Milestone Religare.
“We are happy to bring on board an equity partner of the stature of Temasek as we begin the next phase of growth. Temasek’s global perspective and long term interest in healthcare makes them a valuable partner. We also welcome Dr. Jennifer Lee to our board and look forward to benefiting from her vast experiences in health management and policy”, said Dr. B.S. Ajaikumar, Chairman and CEO of HCG Enterprises Ltd.
“We are pleased to have the opportunity to invest in HCG, who have redefined cancer care in India," said Rohit Sipahimalani, Head- India, Temasek Holdings.